Camlin Fine Sciences Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 3,858.86 million compared to INR 3,878.35 million a year ago. Revenue was INR 3,875.5 million compared to INR 3,975.98 million a year ago. Net loss was INR 117.86 million compared to net income of INR 240.44 million a year ago. Basic loss per share from continuing operations was INR 0.71 compared to basic earnings per share from continuing operations of INR 1.73 a year ago. Diluted loss per share from continuing operations was INR 0.7 compared to diluted earnings per share from continuing operations of INR 1.71 a year ago.
For the nine months, sales was INR 12,113.68 million compared to INR 12,548.56 million a year ago. Revenue was INR 12,211.61 million compared to INR 12,648.41 million a year ago. Net loss was INR 156.14 million compared to net income of INR 429.46 million a year ago. Basic loss per share from continuing operations was INR 0.94 compared to basic earnings per share from continuing operations of INR 2.86 a year ago. Diluted loss per share from continuing operations was INR 0.93 compared to diluted earnings per share from continuing operations of INR 2.83 a year ago.